Nianping Chen
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Medicinal plant effects and applications
Papers in
-
- Biological Activity of Diterpenoids and Biflavonoids 2
- RNA modifications and cancer 2
- Oncology 5
- Cancer-related Molecular Pathways 3
- PARP inhibition in cancer therapy 2
- Co-authors
- Mingyi Li (10 shared papers)Runzhi Zhu (6 shared papers)Jie Liu (4 shared papers)Qingyu Zhang (4 shared papers)Huilai Miao (7 shared papers)Juan Xia (2 shared papers)Juntao Liu (2 shared papers)Qingyu Zhang (2 shared papers)
In The Last Decade
Nianping Chen
18 papers receiving 465 citations
Peers
Comparison fields: 5 of 69
- Geriatrics and Gerontology 61
- Complementary and alternative medicine 65
- Hepatology 46
- Cancer Research 76
- Molecular Biology 241
Countries citing papers authored by Nianping Chen
This map shows the geographic impact of Nianping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianping Chen more than expected).
Fields of papers citing papers by Nianping Chen
This network shows the impact of papers produced by Nianping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianping Chen. The network helps show where Nianping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Nianping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 74 | |
| 2 | 2014 | 68 | |
| 3 | 2014 | 51 | |
| 4 | 2015 | 44 | |
| 5 | 2013 | 42 | |
| 6 | 2012 | 40 | |
| 7 | 2014 | 28 | |
| 8 | 2016 | 26 | |
| 9 | 2016 | 24 | |
| 10 | 2014 | 13 | |
| 11 | 2024 | 13 | |
| 12 | 2020 | 11 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2020 | 3 | |
| 17 | 2021 | 2 | |
| 18 | 2023 | 1 |
About Nianping Chen
Nianping Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Geriatrics and Gerontology and Hepatology, having authored 18 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Cancer, Lipids, and Metabolism (2 papers), Medicinal plant effects and applications (2 papers), Biological Activity of Diterpenoids and Biflavonoids (2 papers), PARP inhibition in cancer therapy (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Geriatrics and Gerontology (61 citations), Complementary and alternative medicine (65 citations), Hepatology (46 citations), Cancer Research (76 citations) and Molecular Biology (241 citations). Nianping Chen has collaborated with scholars based in China, Hong Kong and Iran. Frequent co-authors include Mingyi Li, Runzhi Zhu, Jie Liu, Qingyu Zhang, Huilai Miao, Juan Xia, Juntao Liu, Qingyu Zhang, Bin Liu and Wei Zhou. Their work appears in journals such as Current Stem Cell Research & Therapy, BioMed Research International, Cancer Medicine, BMC Surgery and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.